Filter
510
Text search:
vaccine
doses
Featured
Recommendations
47
New Publications
115
Language
Document type
No document type
237
Studies & Reports
82
Guidelines
79
Fact sheets
30
Strategic & Response Plan
27
Manuals
21
Situation Updates
15
Training Material
8
Resource Platforms
5
Infographics
3
Brochures
2
App
1
Countries / Regions
Global
23
India
21
South Africa
14
Africa
14
Brazil
13
Kenya
12
Congo, Democratic Republic of
11
Latin America and the Carribbean
11
Nigeria
8
Ethiopia
8
Malawi
8
Syria
7
Sierra Leone
6
Uganda
6
Zimbabwe
6
Bangladesh
6
Ghana
5
Philippines
5
Nepal
5
Tanzania
5
Ukraine
5
Lesotho
5
Western and Central Europe
5
Liberia
4
Cameroon
4
South Sudan
4
Zambia
4
Rwanda
4
Namibia
4
West and Central Africa
4
Pakistan
3
Afghanistan
3
Mozambique
3
East and Southern Africa
3
Middle East and North Africa
3
South–East Asia Region
3
Venezuela
3
Eastern Europe
3
Haiti
2
Lebanon
2
Cambodia
2
Papua New Guinea
2
Colombia
2
Chile
2
Russia
2
Burkina Faso
1
Togo
1
Somalia
1
Iraq
1
Germany
1
Chad
1
Central African Republic
1
North Macedonia
1
El Salvador
1
Angola
1
Myanmar / Burma
1
Yemen
1
Other region
1
Asia
1
Tajikistan
1
Authors & Publishers
Publication Years
Category
Countries
197
Clinical Guidelines
74
Women & Child Health
42
Public Health
23
Key Resources
23
Pharmacy & Technologies
4
Capacity Building
2
Toolboxes
COVID-19
122
Polio
23
Rapid Response
20
NTDs
19
HIV
18
TB
17
Ebola & Marburg
12
Conflict
12
Cholera
11
AMR
11
Refugee
8
Pharmacy
8
Planetary Health
6
Mental Health
5
Caregiver
5
Natural Hazards
4
Health Financing Toolbox
4
2.0 Rapid Response
4
Zika
3
Global Health Education
3
NCDs
3
Malaria
3
Specific Hazards
2
Disability
1
Interim recommendations for use of the inactivated COVID-19 vaccine, CoronaVac, developed by Sinovac
These WHO interim recommendations for use of the Sinovac-CoronaVac were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.
This document has been updat
...
Interim guidance, 26 October 2021
This interim guidance has been developed on the basis of the advice issued by the Strategic Advisory Group of Experts (SAGE) on Immunization at its meeting on 5 October 2021.
SAGE said moderately and severely immunocompromised persons should be offered an addition
...
Interim Guidance, 12 July 2021; This tool was developed to assess present and surge capacities for the treatment of COVID-19 in health facilities. It allows health facilities to assess the availability and status of stockout of critical COVID-19 medicines, equipment and supplies on site and to ident
...
Mass vaccination campaigns to prevent coronavirus disease 2019 (Covid-19) are occurring in many countries; estimates of vaccine effectiveness are urgently needed
to support decision making. A countrywide mass vaccination campaign with the
use of
...
Training on handling, storing and transporting Pfizer BioNTech COVID-19 Vaccine COMIRNATY® (Tozinameran)
recommended
4 August 2021. Currently, Pfizer BioNTech COVID-19 Vaccine COMIRNATY® (Tozinameran) is the only COVID-19 vaccine that should be stored and transported at -60ºC to -86ºC ultra-low temperature (ULT
...
Vatican lays out 20 points for a universal and fair destination of vaccines, for a fairer and healthier world
Published:February 02, 2021DOI:https://doi.org/10.1016/S0140-6736(21)00234-8
Vaccine handling, storage and Transportation of Pfizer BioNTech
COVID-19 COMIRNATY® (Tozinameran)
This article is part four in a series of explainers on vaccine development and distribution.
Part one focused on how vaccines work to protect our bodies from disease-carrying germs.
Part two focused on the ingredients in a
...
WHO lists 9th COVID-19 vaccine for emergency use to expand vaccination access in low-income countries, 17 December 2021
Interim recommendations for the use of ChAdOx1-S [recombinant] COVID-19 vaccine (AstraZeneca COVID-19 AZD1222 Vaxzevria™, SII COVISHIELD™ vaccine) - Last updated 30 July 2021
WHO strongly recommends discontinuation of the nerve tissue vaccine, and replacement with modern concentrated and purified cell culture derived vaccines (CCDV) and embryonated eggbased rabies vaccines.
These vaccines must comply with WHO criteria f
...
24 May 2021; Guidance for vaccinators on how to store, prepare, draw up and administer COVID-19 vaccines Updated May 2021 · Western Cape Edition
Practical Approach to Care Kit: Vaccine
This is a part of a series of lesson plans created by Peace Corps volunteers in Senegal about vaccine preventable diseases
In many countries neonatal tetanus is responsible for half of all neonatal deaths due to vaccine-preventable diseases and for almost 14% of al¡ infant deaths. It is estimated that in the 1970s more than 10,000 newborns died annually from neonatal t
...
Since May 2019, Confirmation of 4 new emergence of type 2 vaccine-derived poliovirus (VDPV2) in Bambari (2) and Bimbo (2) health districts without any genetic link between them and other known viruses ; Bambari Health District: CAF-RS4-BAM-19-058, o
...
The overall goal of this strategy is to ensure accurate understanding of the
benefits of covid-19 vaccination and alleviate apprehension about the vaccine, to ensure its acceptance and encourage uptake across various audiences.
Objectives
x Creat
...
This publication is a companion document to the NDVP National Deployment and Vaccination Plans guidance, which provides a framework for countries to develop their national strategies. As countries face challenges with erratic vaccine supplies, use
...
When situations occur in which unwanted events are rightly or wrongly connected with vaccination, they may erode confidence in vaccines and the authorities delivering them. This document presents the scientific evidence behind WHO’s recommendations on building and restoring confidence in vaccines
...
